4th Quarter - Termination — CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.… for NAVIGENICS, INC. (2011)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.

Client

NAVIGENICS, INC.

Income

$10,000

Expenses

—

Terminated

Nov 30, 2011

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Termination (this page)	Jan 18, 2012	$10,000	Replaced
4th Quarter - Termination Amendment	Dec 31, 2012	$10,000	Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Oversight and regulation of genetic testing Direct to consumer genetic testing

Lobbyist	Covered position, as disclosed
JENNIFER RACHEL LEIB	—

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Oversight and regulation of genetic testing. Direct to consumer genetic testing.

Lobbyist	Covered position, as disclosed
JENNIFER RACHEL LEIB	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE

Consumer Issues/Safety/Products CSP

Direct to consumer genetic testing.

Lobbyist	Covered position, as disclosed
JENNIFER RACHEL LEIB	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.